Skip to main navigation Skip to search Skip to main content

Short-term high-dose steroid therapy in a case of rhabdomyolysis refractory to intravenous fluids

  • Fnu Zarlasht
  • , Mashal Salehi
  • , Alamgir Sattar
  • , Mohammad Abu-Hishmeh
  • , Muzammil Khan
  • New York City Health + Hospitals
  • Harlem Hospital Center

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Objective: Unusual or unexpected effect of treatment Background: Rhabdomyolysis is a syndrome characterized by skeletal muscle breakdown, that involves the release of intracellular contents into the circulation, including creatine kinase (CK), myoglobin, electrolytes, organic acids, and purines. Causes of rhabdomyolysis include trauma, exertion, drugs, and toxins (including alcohol), and electrolyte abnormalities. The treatment of rhabdomyolysis is to remove the cause and use intravenous (IV) fluids. When this treatment strategy fails to work, high-dose IV steroids may be used. Case Report: We present a case of rhabdomyolysis following the use of 3,4-methylenedioxy-methamphetamine (MDMA) or ‘ecstasy’ with hypophosphatemia, which was found to be refractory to intravenous hydration. In this case, pulsed dosing of steroid therapy was found to be effective. Conclusions: Rhabdomyolysis that is refractory to treatment with IV fluids may respond to a short-term, high-dose course of IV steroids.

Original languageEnglish
Pages (from-to)1110-1113
Number of pages4
JournalAmerican Journal of Case Reports
Volume18
DOIs
StatePublished - Oct 17 2017

Keywords

  • Creatine kinase
  • N-methyl-3,4-methylenedioxyamphetamine
  • Rhabdomyolysis

Fingerprint

Dive into the research topics of 'Short-term high-dose steroid therapy in a case of rhabdomyolysis refractory to intravenous fluids'. Together they form a unique fingerprint.

Cite this